Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial

References

• LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
   PubMed Web of Science ®Google Scholar
• CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• BarrRGBluemkeDAAhmedFSPercent emphysema, airflow obstruction, and impaired left ventricular fillingN Engl J Med2010362321722720089972
   PubMed Web of Science ®Google Scholar
• WatzHWaschkiBMeyerTDecreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflationChest20101381323820190002
   PubMed Web of Science ®Google Scholar
• GrauMBarrRGLimaJAPercent emphysema and right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle StudiesChest2013144113614423450302
   PubMed Web of Science ®Google Scholar
• AtherSChanWBozkurtBImpact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fractionJ Am Coll Cardiol20125911998100522402071
   PubMed Web of Science ®Google Scholar
• SethHDSultanSGotfriedMHRole of indacaterol, a once-daily bronchodilator, in chronic obstructive pulmonary diseaseJ Thorac Dis20135680681424409359
   PubMed Web of Science ®Google Scholar
• BeehKMBeierJIndacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseasesAdv Ther200926769169919609496
   PubMed Web of Science ®Google Scholar
• BuhlRDunnLJDisdierCINTENSITY study investigatorsBlinded 12-week comparison of once-daily indacaterol and tiotropium in COPDEur Respir J201138479780321622587
   PubMed Web of Science ®Google Scholar
• ChapmanKRRennardSIDograAOwenRLassenCKramerBINDORSE Study InvestigatorsLong-term safety and efficacy of indacaterol, a long-acting β2-agonist, in subjects with COPD: a randomized, placebo-controlled studyChest20111401687521349928
   PubMed Web of Science ®Google Scholar
• DahlRChungKFBuhlRINVOLVE (INdacaterol: Value in COPD: Longer Term Validation of Efficacy and Safety) Study InvestigatorsEfficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPDThorax201065647347920522841
   PubMed Web of Science ®Google Scholar
• DonohueJFFogartyCLötvallJINHANCE Study InvestigatorsOnce-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropiumAm J Respir Crit Care Med2010182215516220463178
   PubMed Web of Science ®Google Scholar
• FeldmanGSilerTPrasadNINLIGHT 1 study groupEfficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week studyBMC Pulm Med2010101120211002
   PubMed Web of Science ®Google Scholar
• KornSKerwinEAtisSAmosCOwenRLassenCINSIST study groupIndacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week studyRespir Med2011105571972621367594
   PubMed Web of Science ®Google Scholar
• KornmannODahlRCentanniSINLIGHT-2 (Indacaterol Efficacy Evaluation Using 150-μg Doses with COPD Patients) study investigatorsOnce-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparisonEur Respir J201137227327920693243
   PubMed Web of Science ®Google Scholar
• LaforceCAumannJde Teresa ParreñoLINTEGRAL Study InvestigatorsSustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: a randomized, crossover studyPulm Pharmacol Ther201124116216820619353
   PubMed Web of Science ®Google Scholar
• RudskiLGLaiWWAfilaloJGuidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of EchocardiographyJ Am Soc Echocardiogr2010237685713 quiz 86–8820620859
   PubMed Web of Science ®Google Scholar
• CazzolaMManteroASantusPDoppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patientsPulm Pharmacol Ther200720325826416600647
   PubMed Web of Science ®Google Scholar
• SantusPRadovanovicDHenchiSAssessment of acute bronchodilator effects from specific airway resistance changes in stable COPD patientsRespir Physiol Neurobiol2014197364524726342
   PubMed Web of Science ®Google Scholar
• RossiACentanniSCerveriIAcute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropiumRespir Med20121061849022035851
   PubMed Web of Science ®Google Scholar
• BoissiereJGautierMMachetMCHantonGBonnetPEderVDoppler tissue imaging in assessment of pulmonary hypertension-induced right ventricle dysfunctionAm J Physiol Heart Circ Physiol20052896H2450H245516055521
   PubMed Web of Science ®Google Scholar
• BoussugesAPinetCMolenatFLeft atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler studyAm J Respir Crit Care Med20001622 Pt 167067510934104
   PubMed Web of Science ®Google Scholar
• BoussugesAMolenatFBurnetHOperation Everest III (Comex ‘97): modifications of cardiac function secondary to altitude-induced hypoxia. An echocardiographic and Doppler studyAm J Resp Crit Care Med2000161126427010619830
   PubMed Web of Science ®Google Scholar
• CazzolaMPageCPRoglianiPMateraMGβ2-agonist therapy in lung diseaseAm J Respir Crit Care Med2013187769069623348973
   PubMed Web of Science ®Google Scholar
• DecramerMLHananiaNALotvallJOYawnBPThe safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis20138536423378756
   PubMed Web of Science ®Google Scholar